Pfizer Enters Definitive Agreement to Acquire Biohaven Pharmaceuticals
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) reported entry into a definitive agreement where Pfizer will acquire Biohaven, maker of NUTREC ODT, a dual-acting migraine therapy approved for acute treatment and episodic prevention of migraine...